MammaPrint

Used in people with early-stage breast cancer, MammaPrint is a genomic test that helps identify patients whose cancer is at high risk of recurring or spreading to other parts of the body. MammaPrint analyzes the activity of a group of 70 genes within a tumor and provides a “high risk” or “low risk” score. Physicians use the results to help guide treatment decisions for patients with certain types of breast cancer. BCRF researcher Laura van ‘t Veer, PhD developed the groundbreaking MammaPrint test.